The Association Between Gout and Cardiovascular Disease Outcomes: Assessment and Recalibration of Individual-level Primary Prevention Risk Prediction Equations in Approximately 450,000 New Zealanders Ken Cai, MBBS, FRACP, MSc – University of Auckland
5:10 PM – 5:20 PM ET
The Comparative Effect of Exposure to Various Risk Factors on the Risk of Hyperuricaemia: Diet Has a Weak Causal Effect Tony R. Merriman, PhD – University of Otago
5:20 PM – 5:30 PM ET
Reducing Immunogenicity of Pegloticase (RECIPE) with Concomitant Use of Mycophenolate Mofetil in Patients with Refractory Gout—a Phase II Double Blind Randomized Controlled Trial Puja Khanna, MD, MPH – University of Michigan
5:30 PM – 5:40 PM ET
Long-term Xanthine Oxidase Inhibitor Treat to Target Urate Lowering Therapy Coordinately Re-wires the Mononuclear Leukocyte Mitochondrial and Inflammatory Proteome in Gout Robert Terkeltaub, MD – VA/UCSD
5:40 PM – 5:50 PM ET
Dual-energy CT Predicts Mortality in Gout Patients: A 3-year Follow-up Cohort Study Tristan Pascart, MD, PhD – Groupement Hospitalier de l'Institut Catholique de Lille
.png "Nicola Dalbeth, MD photo")
